8-K

Lunai Bioworks Inc. (LNAI)

8-K 2024-03-05 For: 2024-02-28
View Original
Added on April 07, 2026

UNITED

STATES SECURITIES AND EXCHANGE COMMISSION

Washington,

DC 20549

FORM 8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2024

RENOVARO

INC.

(Exact name of registrant as specified in its charter)

Delaware 001-38751 45-2559340
(State<br> or other jurisdiction (Commission<br> File Number) (I.R.S.<br> Employer
of<br> incorporation) Identification<br> No.)

2080Century Park East, Suite 906

LosAngeles, CA 90067

(Address of principal executive offices)

+1 (305) 918-1980

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications<br> pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant<br> to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications<br> pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications<br> pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class Trading Symbol Name of Each Exchange on Which Registered
Common<br> Stock, par value $0.0001 per share RENB The<br> Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or PrincipalOfficers; Election of Directors; Appointment of Principal Officers.

Luisa Puche tendered her resignation as Chief Financial Officer of Renovaro Inc. (the “Company”), effective as of March 21, 2024. She submitted her resignation on February 28, 2024. An experienced Interim-CFO candidate has been identified. The Company has entered into contract negotiations in an effort to provide overlap with Ms. Puche to help ensure a smooth transition. In addition, Ms. Puche has agreed to continue, if needed, in a consulting role. Ms. Puche’s resignation is not a result of any disagreement between herself and the Company, its management, the Company's Board of Directors (the “Board”) or any committee of the Board. The Company appreciates Ms. Puche’s diligent service as Chief Financial Officer and wishes her success in her future endeavors.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RENOVARO INC.
By: /s/ Mark Dybul, M.D.
Name: Mark Dybul<br><br>Title: Chief Executive Officer

Date: March 5, 2024